Using this method, we examined the utility of IgM-free AIM as a diagnostic biomarker for HCC in each group of etiologies causing HCC by analyzing serum samples collected from patients with NASH, hepatitis B virus (HBV), and hepatitis C virus (HCV). The gene discussed is CD40LG; the disease is hepatocellular carcinoma.